Shandong Weigao Group Medical Polymer Company Limited released its monthly return for November 2025, disclosing no adjustments to its total authorized share capital of RMB 457,063,232.4. The H shares authorized capital remained at 4,522,332,324 shares, par value RMB 0.1 each, while non-listed shares remained at 48,300,000, also par value RMB 0.1 each.
The total number of issued H shares (excluding treasury shares) decreased by 4,933,200 during the month, from 4,500,049,524 to 4,495,116,324. Correspondingly, treasury shares increased by 4,933,200, bringing the total to 27,216,000. All repurchases were recorded at prices ranging from HKD 5.2587 to HKD 5.6325. The total number of issued non-listed shares remained unchanged at 48,300,000.
Comments